244 related articles for article (PubMed ID: 23380674)
1. Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat.
Ryan PJ; Büchler E; Shabanpoor F; Hossain MA; Wade JD; Lawrence AJ; Gundlach AL
Behav Brain Res; 2013 May; 244():142-51. PubMed ID: 23380674
[TBL] [Abstract][Full Text] [Related]
2. Chronic activation of the relaxin-3 receptor on GABA neurons in rat ventral hippocampus promotes anxiety and social avoidance.
Rytova V; Ganella DE; Hawkes D; Bathgate RAD; Ma S; Gundlach AL
Hippocampus; 2019 Oct; 29(10):905-920. PubMed ID: 30891856
[TBL] [Abstract][Full Text] [Related]
3. Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL/6J mice.
Zhang C; Chua BE; Yang A; Shabanpoor F; Hossain MA; Wade JD; Rosengren KJ; Smith CM; Gundlach AL
Behav Brain Res; 2015 Oct; 292():125-32. PubMed ID: 26057358
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats.
de Ávila C; Chometton S; Lenglos C; Calvez J; Gundlach AL; Timofeeva E
Behav Brain Res; 2018 Jan; 336():135-144. PubMed ID: 28864207
[TBL] [Abstract][Full Text] [Related]
5. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3-RXFP3 signalling.
Kania A; Gugula A; Grabowiecka A; de Ávila C; Blasiak T; Rajfur Z; Lewandowski MH; Hess G; Timofeeva E; Gundlach AL; Blasiak A
J Physiol; 2017 Jun; 595(11):3425-3447. PubMed ID: 28098344
[TBL] [Abstract][Full Text] [Related]
7. Relaxin-3 receptor (Rxfp3) gene knockout mice display reduced running wheel activity: implications for role of relaxin-3/RXFP3 signalling in sustained arousal.
Hosken IT; Sutton SW; Smith CM; Gundlach AL
Behav Brain Res; 2015 Feb; 278():167-75. PubMed ID: 25257104
[TBL] [Abstract][Full Text] [Related]
8. Central relaxin-3 receptor (RXFP3) activation impairs social recognition and modulates ERK-phosphorylation in specific GABAergic amygdala neurons.
Albert-Gasco H; Sanchez-Sarasua S; Ma S; García-Díaz C; Gundlach AL; Sanchez-Perez AM; Olucha-Bordonau FE
Brain Struct Funct; 2019 Jan; 224(1):453-469. PubMed ID: 30368554
[TBL] [Abstract][Full Text] [Related]
9. Central relaxin-3 receptor (RXFP3) activation increases ERK phosphorylation in septal cholinergic neurons and impairs spatial working memory.
Albert-Gascó H; García-Avilés Á; Moustafa S; Sánchez-Sarasua S; Gundlach AL; Olucha-Bordonau FE; Sánchez-Pérez AM
Brain Struct Funct; 2017 Jan; 222(1):449-463. PubMed ID: 27146679
[TBL] [Abstract][Full Text] [Related]
10. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
[TBL] [Abstract][Full Text] [Related]
11. RLN3/RXFP3 Signaling in the PVN Inhibits Magnocellular Neurons via M-like Current Activation and Contributes to Binge Eating Behavior.
Kania A; Szlaga A; Sambak P; Gugula A; Blasiak E; Micioni Di Bonaventura MV; Hossain MA; Cifani C; Hess G; Gundlach AL; Blasiak A
J Neurosci; 2020 Jul; 40(28):5362-5375. PubMed ID: 32532885
[TBL] [Abstract][Full Text] [Related]
12. Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus.
Ganella DE; Callander GE; Ma S; Bye CR; Gundlach AL; Bathgate RA
Gene Ther; 2013 Jul; 20(7):703-16. PubMed ID: 23135160
[TBL] [Abstract][Full Text] [Related]
13. Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice.
Smith CM; Chua BE; Zhang C; Walker AW; Haidar M; Hawkes D; Shabanpoor F; Hossain MA; Wade JD; Rosengren KJ; Gundlach AL
Behav Brain Res; 2014 Jul; 268():117-26. PubMed ID: 24681162
[TBL] [Abstract][Full Text] [Related]
14. The putative role of the relaxin-3/RXFP3 system in clinical depression and anxiety: A systematic literature review.
Wong WLE; Dawe GS; Young AH
Neurosci Biobehav Rev; 2021 Dec; 131():429-450. PubMed ID: 34537263
[TBL] [Abstract][Full Text] [Related]
15. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
Kristensson L; Mayer G; Ploj K; Wetterlund M; Arlbrandt S; Björquist A; Wissing BM; Castaldo M; Larsson N
Eur J Pharmacol; 2015 Jan; 747():123-31. PubMed ID: 25496752
[TBL] [Abstract][Full Text] [Related]
16. Regulation of expression of relaxin-3 and its receptor RXFP3 in the brain of diet-induced obese rats.
Lenglos C; Mitra A; Guèvremont G; Timofeeva E
Neuropeptides; 2014 Jun; 48(3):119-32. PubMed ID: 24629399
[TBL] [Abstract][Full Text] [Related]
17. Central amygdala relaxin-3/relaxin family peptide receptor 3 signalling modulates alcohol seeking in rats.
Walker LC; Kastman HE; Krstew EV; Gundlach AL; Lawrence AJ
Br J Pharmacol; 2017 Oct; 174(19):3359-3369. PubMed ID: 28726252
[TBL] [Abstract][Full Text] [Related]
18. Estrous Cycle Modulation of Feeding and Relaxin-3/Rxfp3 mRNA Expression: Implications for Estradiol Action.
de Ávila C; Chometton S; Calvez J; Guèvremont G; Kania A; Torz L; Lenglos C; Blasiak A; Rosenkilde MM; Holst B; Conrad CD; Fryer JD; Timofeeva E; Gundlach AL; Cifani C
Neuroendocrinology; 2021; 111(12):1201-1218. PubMed ID: 33333517
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system.
Sutton SW; Shelton J; Smith C; Williams J; Yun S; Motley T; Kuei C; Bonaventure P; Gundlach A; Liu C; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():242-9. PubMed ID: 19416196
[TBL] [Abstract][Full Text] [Related]
20. Relaxin-3 receptor (RXFP3) activation in the nucleus of the solitary tract modulates respiratory rate and the arterial chemoreceptor reflex in rat.
Furuya WI; Dhingra RR; Gundlach AL; Hossain MA; Dutschmann M
Respir Physiol Neurobiol; 2020 Jan; 271():103310. PubMed ID: 31568840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
